Common use of Time to Consider, Consult With Counsel and Revoke Clause in Contracts

Time to Consider, Consult With Counsel and Revoke. (a) The Company is presenting Executive with this Transition Agreement on September 10, 2018 and Executive has until close of business on October 1, 2018 to consider it. Executive acknowledge that Executive has been given at least twenty-one (21) days to consider this Transition Agreement before signing it, and agrees that any changes made to the terms of this Transition Agreement shall not restart the twenty-one (21) day period. (b) Executive acknowledges that Executive has been advised by the Company, in writing, to consult an attorney with respect to this Transition Agreement before signing it. Executive has the right to revoke this Transition Agreement after signing it by written notice to the Company sent by reputable overnight courier or email not more than seven (7) days after the date of Executive’s execution of this Transition Agreement. Notice of revocation should be addressed to BioTime, Inc., 0000 Xxxxxxxx Xxxxxx, Xxxxx 000, Xxxxxxx, XX 00000, ATTN: General Counsel or if by email, addressed to xxxxx@xxxxxxxxxx.xxx. If Executive chooses to revoke this Transition Agreement, it shall be null and void and without limiting the generality of the foregoing, Executive shall no longer be entitled to the pay and benefits under Section 2 or any other Section of this Transition Agreement other than the Accrued Benefits described in Section 3. Executive expressly acknowledges that the payments and benefits described in Section 2 represent amounts to which he has no legal entitlement unless he executes, and does not revoke, this Transition Agreement.

Time to Consider, Consult With Counsel and Revoke. (a) The Company is presenting Executive with this Transition Agreement on September 10, 2018 and Executive has until close of business on October 1, 2018 to consider it. Executive acknowledge that Executive has been given at least twenty-one (21) days to consider this Transition Agreement before signing it, and agrees that any changes made to the terms of this Transition Agreement shall not restart the twenty-one (21) day period. (b) Executive acknowledges that Executive has been advised by the Company, in writing, to consult an attorney with respect to this Transition Agreement before signing it. Executive has the right to revoke this Transition Agreement after signing it by written notice to the Company sent by reputable overnight courier or email not more than seven (7) days after the date of Executive’s execution of this Transition Agreement. Notice of revocation should be addressed to BioTime, Inc., 0000 1000 Xxxxxxxx Xxxxxx, Xxxxx 000, Xxxxxxx, XX 00000, ATTN: General Counsel or if by email, addressed to xxxxx@xxxxxxxxxx.xxxlxxxx@xxxxxxxxxx.xxx. If Executive chooses to revoke this Transition Agreement, it shall be null and void and without limiting the generality of the foregoing, Executive shall no longer be entitled to the pay and benefits under Section 2 or any other Section of this Transition Agreement other than the Accrued Benefits described in Section 3. Executive expressly acknowledges that the payments and benefits described in Section 2 represent amounts to which he has no legal entitlement unless he executes, and does not revoke, this Transition Agreement.

Time to Consider, Consult With Counsel and Revoke. (a) The Company is presenting Executive with this Transition Agreement on September 10July 1, 2018 2019 and Executive has until close of business on October 1July 22, 2018 2019 to consider it. Executive acknowledge that Executive has been given at least twenty-one (21) days to consider this Transition Agreement before signing it, and agrees that any changes made to the terms of this Transition Agreement shall not restart the twenty-one (21) day period. (b) Executive acknowledges that Executive has been advised by the Company, in writing, to consult an attorney with respect to this Transition Agreement before signing it. . (c) Executive has the right to revoke this Transition Agreement after signing it by written notice to the Company sent by reputable overnight courier or email not more than seven (7) days after the date of Executive’s execution of this Transition Agreement. Notice of revocation should be addressed to BioTimeOncoCyte Corporation, Inc., 0000 1000 Xxxxxxxx Xxxxxx, Xxxxx 000, Xxxxxxx, XX 00000, ATTN: General Counsel Axxxxx Xxxxxx, Chief Operating Officer, or if by email, addressed to xxxxx@xxxxxxxxxx.xxxaxxxxxx@xxxxxxxx.xxx. If Executive chooses to revoke this Transition Agreement, it shall be null and void and without limiting the generality of the foregoing, Executive shall no longer be entitled to the pay and benefits under Section 2 and Section 4 of this Transition Agreement or any other Section of this Transition Agreement other than the Accrued Benefits described in Section 3. Executive expressly acknowledges that the payments and benefits described in Section 2 and Section 4 of this Transition Agreement represent amounts payments and benefits to which he Executive has no legal entitlement unless he Executive executes, and does not revoke, this Transition Agreement.

Time to Consider, Consult With Counsel and Revoke. (a) The Company is presenting Executive with this Transition Separation Agreement on September 10October 15, 2018 and Executive has until close of business on October 1November 5, 2018 to consider it. Executive acknowledge that Executive has been given at least twenty-one (21) days to consider this Transition Separation Agreement before signing it, and agrees that any changes made to the terms of this Transition Separation Agreement shall not restart the twenty-one (212 1) day period. (b) Executive acknowledges that Executive has been advised by the Company, in writing, to consult an attorney with respect to this Transition Separation Agreement before signing it. Executive has the right to revoke this Transition Separation Agreement after signing it by written notice to the Company sent by reputable overnight courier or email not more than seven (7) days after the date of Executive’s execution of this Transition Separation Agreement. Notice of revocation should be addressed to BioTimeAgeX Therapeutics, Inc., 0000 1000 Xxxxxxxx Xxxxxx, Xxxxx 000, Xxxxxxx, XX 00000, ATTN: General Counsel CEO or if by email, addressed to xxxxx@xxxxxxxxxx.xxxmxxxx@xxxxxxx.xxx. If Executive chooses to revoke this Transition Separation Agreement, it shall be null and void and without limiting the generality of the foregoing, Executive shall no longer be entitled to the pay and benefits under Section 2 or any other Section of this Transition Separation Agreement other than the Accrued Benefits accrued benefits described in Section 3. Executive expressly acknowledges that the payments and benefits described in Section 2 represent amounts valuable benefits to which he has no legal entitlement unless he executes, and does not revoke, this Transition Separation Agreement.

Time to Consider, Consult With Counsel and Revoke. (a) The Company is presenting Executive with this Transition Separation Agreement on September 10January 4, 2018 2019 and Executive has until close of business on October 1January 25, 2018 2019 to consider it. Executive acknowledge that Executive has been given at least twenty-one (21) days to consider this Transition Separation Agreement before signing it, and agrees that any changes made to the terms of this Transition Separation Agreement shall not restart the twenty-one (21) day period. (b) Executive acknowledges that Executive has been advised by the Company, in writing, to consult an attorney with respect to this Transition Separation Agreement before signing it. Executive has the right to revoke this Transition Separation Agreement after signing it by written notice to the Company sent by reputable overnight courier or email not more than seven (7) days after the date of Executive’s execution of this Transition Separation Agreement. Notice of revocation should be addressed to BioTimeOncoCyte Corporation, Inc., 0000 1000 Xxxxxxxx Xxxxxx, Xxxxx 000, Xxxxxxx, XX 00000, ATTN: General Counsel VP, Human Resources, Txxxxx Xxxxx, or if by email, addressed to xxxxx@xxxxxxxxxx.xxxtxxxxx@xxxxxxxxxx.xxx. If Executive chooses to revoke this Transition Separation Agreement, it shall be null and void and without limiting the generality of the foregoing, Executive shall no longer be entitled to the pay and benefits under Section 2 or any other Section of this Transition Separation Agreement other than the Accrued Benefits described in Section 3. Executive expressly acknowledges that the payments and benefits described in Section 2 represent amounts to which he she has no legal entitlement unless he she executes, and does not revoke, this Transition Separation Agreement.